| 12.06 |  +0.05 / +0.42% |
Data as of 4:00pm ET | Day’s Change |
| 12.06 |  0.00 / 0.00% |
Volume: 0.00 |
| Previous close | 12.01 |
| Today’s open | 12.06 |
| Day’s range | 11.71 - 12.12 |
| Volume | 430,513 |
| Average volume (3 months) | 519,671 |
| Market cap | $801.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -88.06% |
| Earnings growth (this year) | -1,098.44% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -31.36% |
| P/E ratio | NM |
| Price/Sales | 9.24 |
| Price/Book | 5.17 |
| Today’s change | Today’s % change | |
|---|---|---|
| AUXLAuxilium Pharmaceuti... | +0.03 | +0.20% |
| ACHNAchillion Pharmaceut... | +0.20 | +2.65% |
| OPTROptimer Pharmaceutic... | -0.27 | -1.84% |
| CBPOChina Biologic Produ... | +0.17 | +0.65% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $53.1M |
| Annual profit (last year) | $5.0M |
| Net profit margin | 9.46% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Kevin C. Gorman, PhD, MBA |
Vice President-Information Technology & Operations Bill Wilson |
Corporate headquarters San Diego, California |
.
